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Abstract
Importance—Reperfusion times for ST elevation myocardial infarction (STEMI) occurring in 
outpatients have improved significantly, but quality improvement efforts have largely ignored 
STEMI occurring in hospitalized patients (inpatient-onset STEMI).
Objective—To define the incidence and variables associated with treatment and outcomes of 
patients who develop STEMI during hospitalization for conditions other than acute coronary 
syndromes (ACS).
Design, Setting and Participants—STEMIs were identified in the 2008–2011 California 
State Inpatient Database.
Exposure—STEMI were classified as inpatient-onset or outpatient-onset based on present-on-
admission codes. Patients who developed STEMI after being hospitalized for ACS were excluded 
from the analysis.
Main Outcome Measures—Regression models were used to evaluate associations between 
location of onset of STEMI, resource utilization and outcomes. Adjustments were made for patient 
age, sex, comorbidities and hospital characteristics.
Results—62021 STEMIs were identified from 303 hospitals of which 3068 (4.9%) occurred in 
patients hospitalized for non-ACS indications. Inpatient-onset STEMI patients were older (71.5 ± 
13.5 vs 64.9 ± 14.1 years; p < 0.001) and more frequently female (47.4% vs 32%; p < 0.001) than 
outpatient-onset STEMI. Inpatient-onset STEMI had higher in-hospital mortality (33.6% vs 9.2%; 
adjusted odds ratio (AOR) = 3.05; 95% CI, 2.76 to 3.38; p < 0.001), were less likely to be 
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discharged home (33.7% vs 69.4%; AOR = 0.38; 95% CI, 0.34 to 0.42; p < 0.001), and were less 
likely to undergo cardiac catheterization (33.8% vs 77.8%; AOR = 0.19; 95% CI, 0.16 to 0.21; p < 
0.001) or percutaneous coronary intervention (21.6% vs 65%; AOR = 0.23; 95% CI, 0.21 to 0.26; 
p < 0.001). Length of stay (13.4 ± 17.8 vs 4.7 ± 6.3 days; adjusted multiplicative effect (AME) = 
2.51; 95% CI, 2.35 to 2.69; p < 0.001) and inpatient charges ($245000 ± 258700 vs $129000 ± 
129800; AME = 2.09; 95% CI, 1.93 to 2.28; p < 0.001) were higher for inpatient-onset STEMI.
Conclusions and Relevance—Patients who developed STEMI while hospitalized for a non-
ACS condition, compared to those with onset of STEMI as an outpatient, were less likely to 
undergo invasive testing or intervention and had a higher in-hospital mortality rate.
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INTRODUCTION
Early reperfusion with percutaneous coronary intervention (PCI) or thrombolytic therapy 
remains the primary goal in the initial treatment of eligible patients presenting to a hospital 
with ST-elevation myocardial infarction (STEMI). Over the last decade, recognition that this 
strategy is of critical importance has prompted the development of a number of regional and 
national initiatives to facilitate and improve systems of care for STEMI. These initiatives, 
including the North Carolina Reperfusion of Acute Myocardial Infarction in Carolina 
Emergency Department (RACE) initiative1, the American College of Cardiology (ACC) 
D2B Alliance2 and the American Heart Association (AHA) Mission: Lifeline initiative3, 
have enhanced recognition, reduced time to treatment, improved systems of care, and 
facilitated access of patients to PCI-capable facilities. Consequently, national median door to 
balloon times improved by over 30 minutes between 2005 and 2010.4
These initiatives have focused exclusively on patients who develop STEMI outside of a 
hospital setting (outpatient-onset STEMI), and little is known about the incidence and 
outcomes of STEMI in patients hospitalized for non-acute coronary syndrome (ACS) 
conditions (inpatient-onset STEMI). In fact, large national databases set up for quality 
improvement such as the NCDR (National Cardiovascular Data Registry) ACTION 
Registry–GWTG (Get With The Guidelines) exclude patients who develop STEMI while 
already hospitalized.5
In a recent single center study, we found that patients who develop inpatient-onset STEMI 
were older and more often female, had more comorbidities, were less likely to receive 
reperfusion therapy, had longer ECG to first device activation times, and were less likely to 
survive than patients with an outpatient STEMI.6 In the current study, we aimed to define 
the incidence and outcomes of inpatient-onset STEMI in a large multi-center cohort. In 
addition, we sought to understand the variables that are associated with the development of 
inpatient-onset STEMI, which may be potential targets for strategies to improve processes 
and systems of care for this population.
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We examined admissions to non-federal hospitals in the state of California using 2008–2011 
discharge data from the State Inpatient Database (CA-SID), which were obtained from the 
Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and 
Quality.7 The CA-SID is an all-payer administrative database including 100% of the state’s 
inpatient discharge records. For the purpose of this study, all records were used except those 
from stand-alone psychiatric hospitals, stand-alone physical and substance use rehabilitation 
facilities, and individuals under the age of 18 years. Each CA-SID record includes: 1. basic 
demographic information, including age, gender, race, and primary payer; 2. up to 30 
International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) 
diagnosis codes; 3. up to 21 ICD-9-CM procedure codes; and 4. outcome information, such 
as discharge disposition, length of stay, and inpatient charges. The CA-SID contains an 
indicator of whether each discharge diagnosis code was present on admission which enabled 
the classification of each STEMI as inpatient-onset or outpatient-onset. CA-SID (covering 
approximately 12% of the US population) was used rather than a national sample because 
the Nationwide Inpatient Sample does not contain present on admission information, which 
would have made it unsuitable for this analysis.
Identification of STEMI-Related Hospital Stays
STEMI-related hospitalizations were identified using diagnosis codes 410.X1, excluding 
410.71 (non-ST elevation myocardial infarction) and 410.91 (acute myocardial infarction 
not otherwise specified) in any position. The validity of using this approach for defining MI 
in administrative data has been previously documented.8 Admissions were classified as 
outpatient-onset or inpatient-onset STEMI based on present on admission codes (Figure 1). 
To improve identification of unambiguously inpatient-onset STEMI, we excluded patients 
with diagnosis codes present on admission that were consistent with non-ST elevation 
myocardial infarction or unstable angina (410.71, 411.1, 411.81, 411.89), as well as angina 
pectoris or chest pain (413.x, 768.50, 768.51, 786.59). For patients with STEMI recorded as 
present on admission, we excluded those who were admitted via transfer from another short 
stay hospital, since we could not discern whether the STEMI was incident at previous 
facility (inpatient-onset STEMI) or prior to admission to the previous facility (outpatient-
onset STEMI).
Identification of cohort at risk of non-cardiac procedure-related inpatient-onset STEMI
In order to evaluate the association between surgical procedures and risk of inpatient-onset 
STEMI, we constructed a supplementary cohort, starting with all adult patients hospitalized 
in acute care hospitals. Patients listed as having ACS, angina, or chest pain present on 
admission were excluded. For the remaining patients, we examined ICD-9-CM procedure 
codes to identify receipt of non-cardiac surgical procedures listed in current ACC/AHA 
guidelines on perioperative cardiovascular care.9 Using these guidelines, ICD-9 procedure 
codes were assigned into three risk categories (low, intermediate and vascular/high risk) as 
well as cardiac surgeries (which were limited to the first two days following admission in an 
effort to identify cardiac surgeries likely preceding STEMI) by two investigators (H.B. and 
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L.Z.) with review of assignments by a third (P.K.); a complete listing of grouped codes is 
provided in Supplementary Table 1. Admissions during which patients received multiple 
surgical procedures that fell into different categories were classified based on the highest 
risk surgical procedure. For patients who had a surgical procedure performed and developed 
a STEMI during the same hospitalization, the assumption was made that the STEMI 
occurred subsequent to the surgical procedure. It was felt unlikely that a surgical procedure 
would have been performed during the same hospitalization following a STEMI.
Identification of STEMI-related treatments, comorbid conditions, and other covariates
Using the data provided in CA-SID records, several additional variables were constructed. 
Using ICD-9-CM procedure codes, we identified potentially STEMI-related treatments 
provided during the stay, including PCI (00.66, 36.01, 36.02, 36.05, 36.06, 36.07, 36.09) and 
cardiac catheterization (37.22, 37.23, 88.5x). Comorbid conditions were identified by 
applying Elixhauser comorbidity criteria to all diagnosis codes listed as present on 
admission.10 The original formulation of the Elixhauser criteria excludes comorbidities 
related to the diagnosis-related group assigned to the inpatient stay; because the objective in 
this analysis was to identify conditions other than STEMI that were present on admission, 
we removed this exclusion.
Development of a model of in-hospital mortality risk
We modeled the association between inpatient mortality and patient age, gender, procedural 
risk category and comorbid conditions, among those patients in the California database who 
did not experience an inpatient-onset STEMI. Using the resultant regression model, we 
estimated the risk of inpatient death among those patients who did experience an inpatient-
onset STEMI, and divided these patients into four quartiles of risk for ease of presentation. 
We then evaluated the association between mortality and the use of PCI in patients in the 
different quartiles and then fit regression models allowing for interactions between 
interventional treatment strategies and the quartiles of patient risk.
Statistical Analyses
Unadjusted comparisons between inpatient-onset and outpatient-onset STEMI patients were 
made using t-tests for continuous variables and chi-squared tests for categorical variables as 
appropriate. To evaluate adjusted comparisons between location of STEMI onset and 
treatment (PCI and cardiac catheterization), outcomes (in-hospital death and discharge to 
home), and resource use (length of stay and inpatient charges), regression models were 
constructed using logistic regression for treatment and outcome endpoints, a negative 
binomial model for the length of stay endpoint, and a generalized linear model with log link 
and gamma distribution for the charges endpoint. All models were adjusted for patient age, 
gender, comorbid conditions present on admission and hospital characteristics (as listed in 
table 1). Unadjusted associations between the rate of non-cardiac surgical risk class and 
incidence of inpatient-onset STEMI were assessed using chi-squared tests, while adjusted 
results were reported using logistic regression. In order to account for potential correlation 
of patients within hospitals, clustered standard errors were used in adjusted regression 
models.
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All inferential statistics were performed using an alpha level of 0.05. Significance testing 
was two-sided. Dataset construction was performed in SAS System, version 9.3 (SAS 
Institute, Cary, NC) and statistical analyses in Stata/SE, version 12.1 (Statacorp, College 
Station, TX). The University of North Carolina at Chapel Hill Institutional Review Board 
exempted this study from review.
RESULTS
Cohort characteristics
Between 2008 and 2011 in the state of California, there were approximately 12 million adult 
hospitalizations in acute care hospitals. After excluding patients who developed STEMI 
after being hospitalized for an ACS or had a STEMI present on transfer from another 
facility, 62021 patients were found to have had a STEMI that was either present on 
admission (outpatient-onset STEMI group) or occurred while hospitalized for a non-ACS 
condition (inpatient-onset STEMI group) from a total of 303 hospitals (Figure 1). Of these, 
58953 (95.1%) were outpatient-onset STEMIs and 3068 (4.9%) were inpatient-onset 
STEMIs. The incidence of inpatient-onset STEMI was 2.7 per 10,000 admissions.
Comparison of inpatient-onset and outpatient-onset STEMI
Patients with inpatient-onset STEMI were older, more often female, and had more 
comorbidities including congestive heart failure, chronic lung disease, renal failure and 
peripheral vascular disease than patients with outpatient-onset STEMI (Table 1). The 
prevalence of hypertension was slightly higher, and the prevalence of diabetes without 
complication slightly lower, in the inpatient-onset STEMI group. The prevalence of diabetes 
with complications was more than twice as high in inpatient-onset STEMI compared to 
outpatient-onset STEMI.
Risks factors associated with inpatient-onset STEMI
Both procedural and patient-level factors were associated with onset of STEMI in 
hospitalized patients (Table 2). After adjustment, those patients who underwent any surgical 
procedure as part of their hospitalization had a higher risk of inpatient-onset STEMI 
compared to those that did not (OR 2.36, 95% CI, 2.17 to 2.58). The risk of inpatient-onset 
STEMI was lowest in patients with no procedure and highest in patients undergoing cardiac 
surgical procedures (Table 3). In total, 49.6% of inpatient-onset STEMIs occurred following 
a surgical procedure. Congestive heart failure, metastatic cancer, coagulopathy, low risk 
surgery, valvular disease and peripheral vascular disease were other variables associated 
with developing inpatient-onset STEMI. In adjusted models in which hospitals were divided 
into quartiles based on number of annual discharges, facility size was not associated with 
occurrence of inpatient-onset STEMI (p = 0.63)
Treatment, clinical outcomes and resource utilization of inpatient-onset STEMI
In unadjusted analyses, patients with inpatient-onset STEMI had worse outcomes and 
greater resource utilization than patients with outpatient-onset STEMI (Table 4). After 
adjustment for age, gender, co-morbidities and hospital characteristics, inpatient-onset 
STEMI patients were less likely to undergo cardiac catheterization (OR = 0.19; 95% CI, 
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0.16 to 0.21; p < 0.001) or PCI (OR = 0.23; 95% CI, 0.21 to 0.26; p < 0.001) than 
outpatient-onset STEMI (table 5). Inpatient-onset STEMI patients consumed greater 
resources as indicated by longer length of stay (multiplicative factor = 2.51; 95% CI, 2.35 to 
2.69; p < 0.001) and inpatient charges (multiplicative factor = 2.09; 95% CI, 1.93 to 2.28; p 
< 0.001). Adjusted in-hospital mortality was more than three times as high for inpatient-
onset STEMI (OR = 3.05; 95% CI, 2.76 to 3.38; p < 0.001) and patients were much less 
likely to be discharged home following an inpatient-onset STEMI (OR = 0.38; 95% CI, 0.34 
to 0.42; p < 0.001).
The association of PCI with survival
To determine whether the use of PCI and/or mortality in patients treated with PCI varied 
with risk, inpatient-onset STEMI patients were divided into quartiles of increasing risk of in-
hospital mortality using a model developed from those patients in the California database 
who did not experience an inpatient-onset STEMI. The use of invasive procedures (cardiac 
catheterization and PCI) decreased in higher risk quartiles (Table 6). However, patients who 
received PCI had higher survival in all quartiles versus those that did not (Table 6). 
Specifically, the odds ratio of mortality associated with PCI in quartile 1 (lowest risk) was 
0.26 (95% CI: 0.16, 0.40), in quartile 2 was 0.37 (95% CI: 0.28, 0.52), in quartile 3 was 0.34 
(95% CI: 0.23, 0.50), and in quartile 4 was 0.57 (95% CI: 0.41, 0.79). A test of linear trend 
for differences across quartile was non-significant (p = 0.10); in pairwise comparisons only 
the comparison between quartile 4 and 1 was statistically significant (p = 0.003).
COMMENT
This multi-center study confirms previously published studies6,11,12 demonstrating increased 
mortality for patients who develop inpatient-onset STEMI compared to outpatient-onset 
STEMI. To the best of our knowledge, the present study is the largest of its kind and the 
only multi-center study specifically assessing the incidence and variables associated with 
outcomes of patients developing STEMI while hospitalized for a non-ACS condition.
In California between 2008 and 2011, patients developing inpatient-onset STEMI had a 
more than 3-fold increase in in-hospital mortality compared to outpatient-onset STEMI 
(33.6% versus 9.2%; p < 0.001). In our own recent single center study of patients developing 
inpatient-onset STEMI after admission for other non-ACS conditions, mortality was 39.6% 
for inpatient-onset STEMI versus 4% for outpatient-onset STEMI6. In the Maximal 
Individual TheRapy in Acute myocardial infarction (MITRA) study, which prospectively 
registered 5,888 patients with STEMI in 54 hospitals in Southwest Germany, inpatient-onset 
STEMI had a two-fold higher in-hospital mortality compared to outpatient-onset STEMI 
(27.3% versus 13.9%).11 Unlike the present study, the MITRA study included inpatient-
onset STEMIs who were admitted with either stable or unstable angina. A retrospective 
study of 7,054 veterans hospitalized for acute MI (STEMI and non-STEMI) in 127 Veterans 
Affairs Hospitals between July 2003 and August 2004, found that the 792 (11.2 %) 
inpatient-onset acute MIs were at a much higher risk of in-hospital and 30-day mortality 
compared to outpatient-onset acute MI.13 Recently, data from 3,795 consecutive STEMI 
patients treated at a single center between March 2003 and January 2013 were reported.12 
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The 83 inpatient-onset STEMIs that were described had a higher 1-year mortality compared 
to outpatient-onset STEMIs that presented via emergency medical services (16.9% versus 
10.3%).
The difference in mortality in the current study between inpatient-onset STEMI and 
outpatient-onset STEMI is at least partially related to those already hospitalized being older, 
having more comorbid conditions and having a concurrent illness or recent surgery. 
However, significant differences in outcomes remained after adjustment for age, gender and 
comorbidities. While it is impossible to completely adjust for confounders in an 
observational study, other potential reasons for differences in mortality should be 
considered. One of these is the lower utilization of cardiac catheterization and primary PCI 
in inpatient-onset STEMI. While primary PCI has not been studied in inpatient-onset 
STEMI, data from outpatient-onset STEMI show that reperfusion in general, and primary 
PCI in particular, improves outcomes.14,15 While the inpatient-onset STEMI population has 
a higher percentage of patients, compared to outpatient-onset STEMI, who are not 
candidates for primary PCI because of excessive risk of bleeding, acute neurological 
symptoms, family and/or patient wishes and/or severe comorbidities,6 there are few data to 
guide these decisions.
This study demonstrates that mortality associated with inpatient-onset STEMI progressively 
increased in patients deemed at higher risk (based upon a model developed from those 
patients in the California database who did not experience an inpatient-onset STEMI). 
Invasive procedures were used less frequently in inpatient-onset STEMI in higher risk 
quartiles but the use of PCI was associated with higher rates of survival in all risk quartiles, 
suggesting that in appropriately selected patients, PCI may be of benefit even among 
patients with comorbid conditions that increase their risk of mortality.
The question of how to improve outcomes and define optimum treatment in hospitalized 
patients who experience a STEMI is an area that merits more attention and concern. While 
there have been improvements in treatment times and clinical outcomes in outpatients who 
have onset of STEMI, few initiatives have focused on optimizing care of hospitalized 
patients with onset of STEMI after admission. Previous studies11–13, including our own6, 
point towards the likelihood that process measures, such as time from onset of symptoms to 
ECG and time from symptom onset to device deployment, play an important role in 
outcomes in this population. Extrapolation of data from outpatient-onset STEMI would 
suggest any benefit with reperfusion would be dependent on the rapidity of restoring 
flow.14,15 Thus, for patients who are candidates for reperfusion, it is likely that delays in 
initiating treatment have a negative impact on outcomes. In our earlier study, we found 
significant delays in recognition of inpatient-onset STEMI, obtaining an ECG, interpreting 
the ECG and making the decision to perform emergency coronary angiography.6 In contrast 
to these delays observed with recognition and decision-making, once the STEMI team was 
activated, there was no difference in reperfusion times between inpatient-onset and 
outpatient-onset STEMI. Garberich et al., reporting data from a single center registry of 
patients diagnosed with STEMI after hospital admission, showed that implementation of a 
standard STEMI protocol for inpatient-onset STEMI resulted in a reduction in in-hospital 
mortality (from 15.4% to 5.3%) with a moderate decrease in median reperfusion times (from 
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85 min to 67 min).11 These data demonstrate that systems designed to improve care of 
inpatient-onset STEMI can have a significant beneficial impact on mortality.
There is no regional or national database that collects information on process measures in 
inpatient-onset STEMI. In fact, large national databases set up for quality improvement 
specifically exclude patients that develop STEMI while already hospitalized. Development 
of a reporting infrastructure, either through existing databases or programs established for 
this purpose, is needed to enhance our understanding of inpatient-onset STEMI.
Multivariable analysis identified several ‘risk factors’ associated with inpatient-onset 
STEMI. There were the traditional risk factors associated with cardiovascular disease 
including age, male gender, diabetes, hypertension, and peripheral vascular disease. There 
were also several factors that have not previously been associated with acute MI including 
paralysis, hypothyroidism, weight loss and metastatic cancer. These results remained 
significant after adjustment for age, gender and comorbidities. Further studies are needed to 
define what role these conditions play in increasing the risk of acute coronary thrombosis.
We found that the risk of inpatient-onset STEMI increased with the complexity of surgical 
procedures as defined by the 2007 ACC/AHA peri-operative guidelines (unchanged in the 
2009 focused update).9 These results mimic studies designed to identify patients at risk for 
peri-operative myocardial infarction and provide further evidence of the discriminative 
power of the categories defined by the guidelines.
Limitations
Our study has several limitations. It is a retrospective, observational analysis, and 
identification of STEMI cases and location of onset were based on administrative data rather 
than adjudicated endpoints. The dataset does not have information on admitting diagnoses, 
elective versus urgent admission or on mortality following discharge. It is possible that the 
numbers presented here underrepresent the problem as patients with inpatient-onset STEMI 
might have died prior to diagnosis. Unobserved case mix measures likely confound the 
estimated association between inpatient-onset STEMI and mortality. If the unobserved case 
mix severity is greater for inpatient STEMI, then our results may overestimate the effect of 
having an inpatient STEMI on mortality and other outcomes. Furthermore, incomplete 
coding of comorbid conditions on hospital claims may limit our ability to completely control 
for severity of disease. The estimated associations remain large however even after 
adjustment for observed covariates, suggesting that some portion of the difference in 
outcomes may be due to delayed recognition and/or lack of revascularization in inpatient 
STEMI. The database does not have information on cause specific mortality, so it is 
unknown whether mortality was related to the STEMI. The most recent data in the CA-SID 
at the time of this study were from 2011 and it is unknown whether the study findings reflect 
current outcomes. We chose to focus on PCI as a reperfusion strategy because the 
limitations of the administrative database prevented us from determining how many STEMI 
patients were treated with thrombolytic therapy. Thrombolytic therapy is commonly used to 
treat select outpatient-onset STEMI at facilities that do not have PCI capability. 
Unfortunately, the limitations of the database also prevented us from determining how many 
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inpatient-onset STEMI would not have been candidates for thrombolytic therapy because of 
elevated bleeding risk.
CONCLUSIONS
In this multi-center, observational study, approximately 5% (2.7 per 10,000 admissions) of 
all STEMIs occurred in patients hospitalized for non-ACS conditions. Patients who 
developed STEMI while hospitalized for a non-ACS condition, compared to those with 
onset of STEMI as an outpatient, were less likely to undergo invasive testing or intervention 
and had a higher in-hospital mortality rate.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cohort flow diagram
Flowchart of cohort identification [US = unstable angina, NSTEMI = non-STEMI].
Kaul et al. Page 11











































Kaul et al. Page 12
Table 1












Age (years; mean (SD)) 65.2 (14.1) 64.9 (14.1) 71.5 (13.5) <0.001
Female 20,316 (32.8%) 18,865 (32.0%) 1,451 (47.4%) <0.001
Race / Ethnicity <0.001
  White 37,701 (63.8%) 35,787 (63.7%) 1,914 (64.9%)
  Black 3,106 (5.3%) 2,928 (5.2%) 178 (6%)
  Hispanic 11,391 (19.3%) 10,913 (19.4%) 478 (16.2%)
  Asian 5,069 (8.6%) 4,756 (8.5%) 313 (10.6%)
  Native American 38 (0.1%) 35 (0.1%) 3 (0.1%)
  Other 1,812 (3.1%) 1,749 (3.1%) 63 (2.1%)
CAD Risk Factors
Hypertension 40,692 (65.6%) 38,588 (65.5%) 2,104 (68.6%) <0.001
Diabetes w/o chronic complications 15,526 (25%) 14,814 (25.1%) 712 (23.2%) 0.02
Diabetes w/ chronic complications 3,538 (5.7%) 3,195 (5.4%) 343 (11.2%) <0.001
Obesity 7,582 (12.2%) 7,279 (12.3%) 303 (9.9%) <0.001
Current Smoker 14,337 (23.1%) 14,032 (23.8%) 305 (9.9%) <0.001
Former Smoker 8,445 (13.6%) 7,964 (13.5%) 481 (15.7%) <0.001
Major Comorbid Conditions
Congestive heart failure 13,456 (21.7%) 12,546 (21.3%) 910 (29.7%) <0.001
Valvular disease 5,358 (8.6%) 4,941 (8.4%) 417 (13.6%) <0.001
Pulmonary circulation disease 1,598 (2.6%) 1,427 (2.4%) 171 (5.6%) <0.001
Peripheral vascular disease 5,056 (8.2%) 4,490 (7.8%) 466 (15.2%) <0.001
Paralysis 1,313 (2.1%) 1,134 (1.9%) 179 (5.8%) <0.001
Other neurological disorders 3,261 (5.3%) 2,948 (5%) 313 (10.2%) <0.001
Chronic pulmonary disease 9,452 (15.2%) 8,718 (14.8%) 734 (23.9%) <0.001
Hypothyroidism 4,861 (7.8%) 4,483 (7.6%) 378 (12.3%) <0.001
Renal failure 7,880 (12.7%) 7,075 (12%) 805 (26.2%) <0.001
Liver disease 1,104 (1.8%) 964 (1.6%) 140 (4.6%) <0.001
Acquired immune deficiency syndrome 160 (0.3%) 152 (0.3%) 8 (0.3%) 0.98
Lymphoma 296 (0.5%) 257 (0.4%) 39 (1.3%) < 0.001
Metastatic cancer 738 (1.2%) 552 (0.9%) 186 (6.1%) <0.001
Solid tumor w/out metastasis 921 (1.5%) 811 (1.4%) 110 (3.6%) <0.001
Peptic ulcer 30 (0.1%) 25 (0.1%) 5 (0.2%) 0.03
Rheumatoid arthritis 1,131 (1.8%) 1,039 (1.8%) 92 (3%) <0.001
Coagulopathy 1,859 (3%) 1,613 (2.7%) 246 (8%) <0.001
Weight loss 1,464 (2.4%) 1,171 (2.0%) 294 (9.6%) <0.001
Fluid and electrolyte disorders 8,748 (14.1%) 7,884 (13.4%) 864 (28.2%) <0.001
































Chronic blood loss anemia 437 (0.7%) 359 (0.6%) 78 (2.5%) <0.001
Deficiency anemia 8,144 (13.1%) 7,296 (12.4%) 848 (27.6%) <0.001
Depression 2,907 (4.7%) 2,694 (4.6%) 213 (6.9%) <0.001
Psychosis 1,286 (2.1%) 1,175 (2.0%) 111 (3.6%) <0.001
Alcohol abuse 2,145 (3.5%) 2,000 (3.4%) 145 (4.7%) <0.001
Drug abuse 1,906 (3.1%) 1,842 (3.1)% 64 (2.1%) <0.001
Hospital Characteristics
PCI capability 53,168 (85.7%) 50,979 (86.5%) 2,189 (71.4%) <0.001
Diagnostic cardiac catheterization only 3,645 (5.9%) 3,345 (5.7%) 300 (9.8%) <0.001
Nocardiac catheterization capability 5,208 (8.4%) 4,629 (7.9%) 579 (18.9%) <0.001
Facility Size (based on annual discharges) <0.001
  Quartile 1 (lowest) 419 (0.7%) 340 (0.6%) 79 (2.6%)
  Quartile 2 5,638 (9.1%) 5,253 (8.9%) 381 (12.4%)
  Quartile 3 16,667 (26.9%) 15,821 (26.8%) 846 (27.6%)
  Quartile 4 (highest) 39,301 (63.4%) 37,539 (63.7%) 1,762 (57.4%)
P-values for comparison of outpatient-onset STEMI vs inpatient-onset STEMI by t-test for continuous variables and chisquared test for binary/
categorical variables. Missing values in gender (59) and race (2904). ‘Other neurological disorders’ is a specific term defined by the Healthcare 
Cost and Utilization Project (HCUP). The mean and range for number of annual discharges was 1422 (172, 2228) for Quartile 1, 4561 (2249, 6111) 
for Quartile 2, 9627 (6112, 12680) for Quartile 3, 19392 (12762, 47502) for Quartile 4.
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Table 2
Associations between patient demographic and clinical characteristics and occurrence of STEMI during 
hospitalizations for non-acute coronary syndrome conditions
Adjusted Odds Ratio [95% CI] P value
Cardiac Surgery* 24.44 [19.41, 30.78] < 0.001
High Risk/Vascular Surgery* 3.48 [2.82, 4.30] < 0.001
Intermediate risk surgery* 2.15 [1.4, 2.38] < 0.001
Low risk surgery* 1.56 [1.37, 1.79] < 0.001
Age (per year) 1.03 [1.03, 1.04] < 0.001
Female gender 0.76 [0.71, 0.82] < 0.001
Comorbid Conditions**
  AIDS 1.41 [0.76, 2.61] 0.28
  Chronic pulmonary disease 1.10 [1.00, 1.21] 0.04
  Coagulopathy 1.58 [1.37, 1.82] < 0.001
  Congestive heart failure 1.71 [1.53, 1.91] < 0.001
  Diabetes w/o chronic complications 1.19 [1.09, 1.30] < 0.001
  Diabetes w/ chronic complications 1.26 [1.09, 1.45] 0.002
  Fluid and electrolyte disorders 1.29 [1.19, 1.40] < 0.001
  Hypertension 1.21 [1.10, 1.32] < 0.001
  Hypothyroidism 0.85 [0.76, 0.96] 0.008
  Liver disease 1.02 [0.84, 1.23] 0.87
  Lymphoma 1.15 [0.84, 1.57] 0.39
  Metastatic cancer 1.74 [1.50, 2.02] < 0.001
  Obesity 1.00 [0.89, 1.13] 0.97
  Paralysis 1.37 [1.18, 1.59] < 0.001
  Peptic ulcer Disease 2.05 [0.89, 4.76] 0.09
  Peripheral vascular disease 1.46 [1.31, 1.63] < 0.001
  Pulmonary circulation disease 0.94 [0.78, 1.12] 0.48
  Renal failure 1.15 [1.04, 1.26] 0.005
  Rheumatoid arthritis 1.14 [0.95, 1.38] 0.17
  Solid tumor w/out metastasis 1.23 [1.02, 1.48] 0.03
  Valvular disease 1.36 [1.21, 1.52] < 0.001
  Weight loss 1.26 [1.09, 1.45] 0.002
Adjustment was made for the variables listed in the table, smoking status, facility characteristics, chronic blood loss anemia, deficiency anemia, 
psychosis, alcohol abuse, drug abuse and calendar year.
*
The comparator group is hospitalized patients who did not undergo surgery.
**
For all variables, comparator group were those patients without STEMI
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Table 3
Covariate-adjusted incidence of STEMI, stratified by ACC/AHA procedural risk classification (per 10000 
admissions)
No Surgery 2.0 ± 0.1
Low risk surgery* 3.1± 0.2
Intermediate risk surgery* 4.2 ± 0.2
High Risk/Vascular Surgery* 6.9 ± 0.7
Cardiac Surgery 47.7 ± 5.2
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Table 5









Predicted mortality rate 
mean (minimum – 
maximum)
1.1% (0.2%–1.7%) 2.4% (1.7%–3.2%) 4.4% (3.2%–6.1%) 12.8% (6.1%–58.2%)
Use of cardiac 
catheterization n (mean 
[95% confidence interval])
358 (46.7% [43.2%, 
50.3%])
287 (37.5% [34.0%, 
41.0%])
212 (27.7% [24.5%, 
31.0%])
179 (23.4% [20.4%, 
26.5%])
Use of PCI n (mean [95% 
confidence interval])
242 (31.6% [28.3%, 
35.0%])
184 (24.0% [21.0%, 
27.2%])
127 (16.6% [14.0%, 
19.4%])
109 (14.3% [11.8%, 
16.9%])
Mortality without PCI n 
(mean [95% confidence 
interval])
138 (26.3% [22.6%, 
30.3%])
208 (35.7% [31.8%, 
39.8%])
256 (40.0% [36.2%, 
44.0%])
294 (44.8% [41.0%, 
48.7%])
Mortality with PCI n 
(mean [95% confidence 
interval])
26 (10.7% [7.1%, 
15.3%])
39 (21.2% [15.5%, 
27.8%])
30 (23.6% [16.5%, 
32.0%])
36 (33.0% [24.3%, 42.7%])
The association between in-hospital mortality and patient age, gender, procedural risk category, and comorbid conditions was modeled among 
those patients in the California database who did not experience an inpatient STEMI. Using the resultant regression model, the risk of in-hospital 
death was determined among those patients with an inpatient STEMI and the patients were divided into four quartiles of risk. For all quartiles, 
mortality was higher without PCI than with PCI (p < 0.001). [PCI = percutaneous coronary intervention]
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